SCHEMBL3230272

SCHEMBL3230272

CCOc1ccc2c(c1)C(C)(c1cc(C(=O)NCCO)ccc1Cl)C(=O)N2S(=O)(=O)c1ccc(C(=O)NC(C)(C)C)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 1/20 0.42
GNRHR P30968 2/20 0.39
EPHX2 P34913 1/20 0.37
NR1H4 Q96RI1 1/20 0.37
MAPT P10636 3/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
DGAT1 O75907 4/20 0.36
TDP1 Q9NUW8 2/20 0.35
POLB P06746 2/20 0.35
RECQL P46063 1/20 0.35
RAB9A P51151 1/20 0.35
HPGD P15428 2/20 0.35
HTT P42858 2/20 0.35
LMNA P02545 2/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3225093 0.92 MAPT (0.42) AVPR1AGNRHREPHX2NR1H4MAPT
SCHEMBL3233778 0.91 AVPR1A (0.41) AVPR1AGNRHREPHX2NR1H4MAPT
SCHEMBL3228428 0.90 AVPR1A (0.43) AVPR1AGNRHREPHX2NR1H4MAPT
SCHEMBL3222818 0.90 AVPR1A (0.44) AVPR1AGNRHREPHX2NR1H4MAPT
SCHEMBL3234467 0.88 AVPR1A (0.42) AVPR1AGNRHREPHX2NR1H4MAPT
SCHEMBL3231069 0.88 AVPR1A (0.47) AVPR1AGNRHRMAPTHTTLMNA
SCHEMBL3233812 0.88 AVPR1A (0.46) AVPR1AMAPTRAB9AHPGDLMNA
SCHEMBL3233628 0.87 AVPR1A (0.43) AVPR1AGNRHREPHX2NR1H4MAPT
SCHEMBL3238705 0.87 AVPR1A (0.44) AVPR1AGNRHRMAPTRECQLRAB9A
SCHEMBL3238699 0.87 AVPR1A (0.44) AVPR1AGNRHRMAPTRECQLRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097374-B1 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPY AS SELECTIVE LIGANDS OF V2 VASOPRESSIN RECEPTORS SANOFI AVENTIS (FR) 2010-06-09 EP claimed
US-20100069384-A1 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPY SANOFI-AVENTIS (FR) 2010-03-18 US claimed
US-20100069384-A1 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPY SANOFI-AVENTIS (FR) 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069384-A1 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPY AVPR2, AVPR1A, AVPR1B AVPR1A 2/4885GNRHR 112/4885EPHX2 2925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.